<div id="readability-page-1"><p>Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have been given a consensus recommendation of &#34;Moderate Buy&#34; by the sixteen research firms that are covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $26.29.</p><p>A number of equities research analysts have recently issued reports on AVTR shares. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Avantor from $23.00 to $25.00 and gave the company a &#34;hold&#34; rating in a research report on Thursday, April 18th. Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an &#34;overweight&#34; rating for the company in a research report on Friday, June 28th. Robert W. Baird cut their price objective on Avantor from $27.00 to $26.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, April 29th. Finally, Evercore ISI cut their price objective on Avantor from $28.00 to $27.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday.</p><p><b>Read Our Latest Research Report on Avantor</b></p><h2>Institutional Trading of Avantor</h2><p>Institutional investors have recently made changes to their positions in the stock. Fifth Third Bancorp grew its stake in shares of Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company's stock valued at $28,000 after buying an additional 694 shares during the period. Livforsakringsbolaget Skandia Omsesidigt grew its stake in shares of Avantor by 565.5% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company's stock valued at $30,000 after buying an additional 1,131 shares during the period. Gladius Capital Management LP purchased a new stake in shares of Avantor during the 4th quarter valued at $42,000. Montag A &amp; Associates Inc. purchased a new stake in shares of Avantor during the 4th quarter valued at $43,000. Finally, TFO Wealth Partners LLC grew its stake in shares of Avantor by 203,100.0% during the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company's stock valued at $46,000 after buying an additional 2,031 shares during the period. 95.08% of the stock is owned by hedge funds and other institutional investors. </p><h2>Avantor Price Performance</h2><p>Shares of AVTR opened at $21.01 on Thursday. Avantor has a twelve month low of $16.63 and a twelve month high of $26.16. The stock's 50 day moving average is $23.56 and its two-hundred day moving average is $23.79. The firm has a market capitalization of $14.27 billion, a PE ratio of 53.87, a P/E/G ratio of 2.15 and a beta of 1.32. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.94. </p><p>Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The company had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the firm earned $0.29 EPS. The company's revenue for the quarter was down 5.6% on a year-over-year basis. Research analysts anticipate that Avantor will post 1.01 earnings per share for the current year. </p><h2>Avantor Company Profile</h2> (Get Free Report<p>Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Avantor</li><li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness </li><li>AbbVie Stock: A Perfect Dip for Investors to Buy</li><li>Are Penny Stocks a Good Fit for Your Portfolio?</li><li>Forget NVIDIA: Super Micro Computer Stock Leads in Momentum</li><li>Top Stocks Investing in 5G Technology</li><li>GitLab Stock Rebounds: The Inside Story of Its Comeback</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFWVFI?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFWVFI"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ The Only Retirement Stock You'll Ever Need? Discover Now <span><span>(From Behind the Markets)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NjM2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NjM2"/></p><h2>Should you invest $1,000 in Avantor right now?</h2><p>Before you consider Avantor, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.</p><p>While Avantor currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p> </div>

AVTR

<p>Avantor, Inc. has received a "Moderate Buy" consensus recommendation from sixteen research firms. Four analysts have rated the stock as a hold, while twelve have given it a buy rating. The average 1-year target price is $26.29. Institutional investors have made changes to their positions in the stock, with 95.08% of the stock owned by hedge funds and other institutional investors. Avantor's stock price has ranged from $16.63 to $26.16 in the past year. The company reported earnings per share of $0.22 for the last quarter.</p>

Avantor, Inc. (NYSE:AVTR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages